| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 12 | +83.33% | -1.10% | +1.10% | -2.20% | -4.12% | — |
| 14d | 12 | +66.67% | -0.44% | +0.95% | -1.39% | -4.52% | — |
| 30d | 12 | +58.33% | -11.96% | +1.35% | -13.32% | -6.80% | — |
| 60d | 12 | +75.00% | -11.55% | +0.91% | -12.46% | -19.50% | — |
| 90d | 12 | +33.33% | -2.79% | +3.56% | -6.35% | -1.77% | — |
| 180d | 12(1 pending) | +36.36% | -14.22% | +12.41% | -26.64% | -15.43% | — |
| 1y | 12(1 pending) | +100.00% | -50.78% | +23.73% | -74.51% | -80.49% | — |
| 2y | 12(3 pending) | +100.00% | -59.65% | +33.75% | -93.39% | -88.05% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 124,000 | — | — | 124,000 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 76,200 | — | — | 76,200 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 76,047 | — | — | 0 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 110,500 | — | — | 110,500 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 113,300 | — | — | 0 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 113,300 | — | — | 113,300 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 76,047 | — | — | 76,047 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 18,198 | — | — | 18,198 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 76,200 | — | — | 0 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 110,500 | — | — | 0 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 124,000 | — | — | 0 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 74,250 | — | — | 74,250 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 18,198 | — | — | 0 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 74,250 | — | — | 0 | Apr 17, 2026 | Apr 17, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 400,000 | — | — | 400,000 | Jan 22, 2026 | Jan 26, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 24,002 | $1.28 | $30.7K | 297,214 | Jan 20, 2026 | Jan 22, 2026 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 113,300 | — | — | 113,300 | Jan 23, 2025 | Jan 27, 2025 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 56,650 | — | — | 319,258 | Jan 23, 2025 | Jan 27, 2025 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 20,148 | $11.20 | $225.7K | 262,608 | Jan 17, 2025 | Jan 22, 2025 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 10,911 | $11.56 | $126.1K | 282,115 | Jul 10, 2024 | Jul 12, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 21,313 | — | — | 293,026 | Jul 9, 2024 | Jul 11, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 21,000 | — | — | 76,047 | May 2, 2024 | May 6, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 21,000 | $2.08 | $43.7K | 271,713 | May 2, 2024 | May 6, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 55,250 | — | — | 249,855 | Jan 23, 2024 | Jan 24, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 110,500 | — | — | 110,500 | Jan 23, 2024 | Jan 24, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 9,781 | $17.23 | $168.5K | 194,605 | Jan 17, 2024 | Jan 19, 2024 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 19,771 | $18.01 | $356.1K | 203,999 | Jul 17, 2023 | Jul 19, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 38,750 | — | — | 223,770 | Jul 14, 2023 | Jul 18, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 30,750 | $2.08 | $64.0K | 185,020 | Jun 13, 2023 | Jun 14, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 30,750 | — | — | 97,047 | Jun 13, 2023 | Jun 14, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 5,800 | $2.08 | $12.1K | 154,270 | Jun 9, 2023 | Jun 12, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 5,800 | — | — | 127,797 | Jun 9, 2023 | Jun 12, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 9,960 | $26.52 | $264.1K | 148,470 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,375 | — | — | 158,430 | Mar 29, 2023 | Mar 31, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 76,200 | — | — | 76,200 | Jan 25, 2023 | Jan 27, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 54,000 | — | — | 138,424 | Jan 25, 2023 | Jan 27, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 12,500 | $2.08 | $26.0K | 96,924 | Jan 23, 2023 | Jan 25, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 30,000 | $35.00 | $1.05M | 84,424 | Jan 23, 2023 | Jan 25, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 17,500 | — | — | 18,198 | Jan 23, 2023 | Jan 25, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 17,500 | $6.22 | $108.8K | 114,424 | Jan 23, 2023 | Jan 25, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 12,500 | — | — | 133,597 | Jan 23, 2023 | Jan 25, 2023 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 4,000 | — | — | 146,097 | Dec 22, 2022 | Dec 27, 2022 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 4,000 | $2.08 | $8.3K | 84,424 | Dec 22, 2022 | Dec 27, 2022 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 9,643 | $19.10 | $184.2K | 80,424 | Dec 20, 2022 | Dec 21, 2022 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,375 | — | — | 90,067 | Dec 19, 2022 | Dec 21, 2022 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 124,000 | — | — | 124,000 | Jan 26, 2022 | Feb 2, 2022 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 20,000 | — | — | 150,097 | Sep 3, 2021 | Sep 3, 2021 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 20,000 | $2.08 | $41.6K | 67,621 | Sep 3, 2021 | Sep 3, 2021 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 20,000 | $2.08 | $41.6K | 47,621 | Mar 5, 2021 | Mar 5, 2021 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 20,000 | — | — | 170,097 | Mar 5, 2021 | Mar 5, 2021 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 74,250 | — | — | 74,250 | Jan 23, 2021 | Jan 26, 2021 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 4,500 | — | — | 190,097 | Dec 21, 2020 | Dec 23, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 4,500 | $2.08 | $9.4K | 27,621 | Dec 21, 2020 | Dec 23, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 14,901 | $30.21 | $450.2K | 23.967 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 11,591 | $2.08 | $24.1K | 34,712 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 846 | $30.72 | $26.0K | 23,121 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 7,143 | $6.22 | $44.4K | 41,855 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,139 | $28.24 | $32.2K | 40,716 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 11,591 | — | — | 194,597 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,143 | — | — | 35,698 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,848 | $29.07 | $53.7K | 38,868 | Dec 1, 2020 | Dec 2, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 27,322 | — | — | 0 | Jun 5, 2020 | Jun 9, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 3,821 | — | — | 23,121 | Jun 5, 2020 | Jun 9, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | SALE Chief Financial Officer | 19,300 | — | — | 206,188 | Apr 30, 2020 | Jun 9, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 19,300 | $2.08 | $40.1K | 19,300 | Apr 30, 2020 | Jun 9, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 42,841 | — | — | 42,841 | Mar 31, 2020 | Jun 9, 2020 ↗ | View → |
| PLRX PLIANT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 27,322 | $13.08 | $357.5K | 27,322 | Feb 28, 2020 | Jun 9, 2020 ↗ | View → |